Christopher Thomas Mallavarapu, MD
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 11
Offices
11 locations · Kaleida Health · General Physician PC · Cupid Medical Psc · Prescott Healthcare Solutions LLC · Cupid Medical of California PC
Hospitals listed: Olean General Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Mallavarapu’s office to ask if they take your plan before you enroll.
State licence records
1 licence
- New Jersey 25MA12040100Medical Doctor · since 2023 · expires 2027-06-30Matched by name, not licence number; check the name before relying on it.ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Results the state published
2017-2019
Risk-adjusted death rates for this physician's own patients, in hospital or within 30 days. Later periods have not been published, so this describes past work.
| Angioplasty (PCI): All PCI | 356 cases, 7 deaths | 1.49% (0.60 to 3.08%) 1.97% seen, 1.60% expected for these patients | No different from the state |
| Angioplasty (PCI): Non-Emergency PCI | 184 cases, 1 deaths | 0.62% (0.01 to 3.42%) 0.54% seen, 0.69% expected for these patients | No different from the state |
See these results hospital by hospital
| Olean General Hosp. — Angioplasty (PCI): All PCI | 356 cases, 7 deaths | 1.49% (0.60 to 3.08%) 1.97% seen, 1.60% expected for these patients | No different from the state |
| Olean General Hosp. — Angioplasty (PCI): Non-Emergency PCI | 184 cases, 1 deaths | 0.62% (0.01 to 3.42%) 0.54% seen, 0.69% expected for these patients | No different from the state |
See 4 earlier periods
2016-2018
| Angioplasty (PCI): All PCI | 366 cases, 9 deaths | 2.12% (0.97 to 4.02%) 2.46% seen, 1.45% expected for these patients | No different from the state |
| Angioplasty (PCI): Non-Emergency PCI | 198 cases, 3 deaths | 1.85% (0.37 to 5.41%) 1.52% seen, 0.68% expected for these patients | No different from the state |
2015-2017
| Angioplasty (PCI): All PCI | 389 cases, 7 deaths | 1.52% (0.61 to 3.13%) 1.80% seen, 1.38% expected for these patients | No different from the state |
| Angioplasty (PCI): Non-Emergency PCI | 206 cases, 3 deaths | 1.54% (0.31 to 4.51%) 1.46% seen, 0.74% expected for these patients | No different from the state |
2014-2016
| Angioplasty (PCI): All PCI | 404 cases, 6 deaths | 1.48% (0.54 to 3.23%) 1.49% seen, 1.19% expected for these patients | No different from the state |
| Angioplasty (PCI): Non-Emergency PCI | 201 cases, 2 deaths | 1.12% (0.13 to 4.04%) 1.00% seen, 0.69% expected for these patients | No different from the state |
2013-2015
| Angioplasty (PCI): All PCI | 285 cases, 3 deaths | 1.14% (0.23 to 3.33%) 1.05% seen, 1.06% expected for these patients | No different from the state |
| Angioplasty (PCI): Non-Emergency PCI | 136 cases, 0 deaths | 0.00% (0.00 to 2.94%) 0.00% seen, 0.68% expected for these patients | No different from the state |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Olean General HospitalOlean, NYAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Kaleida Health, which runs 4 hospitals in 2 statesPatients rate it 2 of 5 · 42% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.173, Oct 2024 – Sep 2025
See every measure and the patient survey for Olean General Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 2 worse of 7 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.173 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0 to 2.05) · 356 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.54 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 208.98 (148.37 to 269.59) · 33 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.7 · 120 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.3 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.3 · 152 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 22 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.9 · 92 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.2 · 1,658 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,789 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.5) · 2,826 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.01 to 5.91) · 349 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 110 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.5 to 3.86) · 331 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.94 (0 to 15.94) · 121 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.66 (3.43 to 11.89) · 100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.23) · 53 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 1.2) · 2,223 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.843 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.133 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.759 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.765 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 235 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -11.5 · 97 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 33.4 · 169 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 14.2 · 431 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 681 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.3 to 7.3) · 115 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (7.4 to 14.3) · 115 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.5 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 698 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.6) · 180 cases | No different | Jan 2024 – Dec 2024 |
What patients said (599 patients answered, 22% of those asked)
| Cleanliness | 1 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 1 |
| Discharge information | 3 |
| Overall hospital rating | 1 |
| Quietness | 1 |
| Recommend hospital | 1 |
| Room was "always" clean | 57% |
| Nurses "always" communicated well | 71% |
| Doctors "always" communicated well | 68% |
| Staff "always" explained | 50% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 61% |
| Doctors "always" listened carefully | 65% |
| Doctors "always" treated them with courtesy and respect | 77% |
| Patients who gave a rating of "9" or "10" (high) | 45% |
| Staff "always" explained new medications | 64% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 42% |
| Staff "always" explained possible side effects | 35% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$781,026
Medicare paid this office $781,026 for 2,422 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,202 | $174,991 | $113 |
| Professional services for outpatient pulmonary rehabilitation with continuous monitoring of blood oxygen, per session | 122 | $161,318 | $79 |
| Ultrasound of both sides of head and neck blood flow | 922 | $135,242 | $147 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 645 | $77,377 | $120 |
| Ultrasound of leg arteries or artery grafts | 336 | $65,932 | $196 |
See all 18 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,202 | $174,991 | $113 |
| Professional services for outpatient pulmonary rehabilitation with continuous monitoring of blood oxygen, per session | 122 | $161,318 | $79 |
| Ultrasound of both sides of head and neck blood flow | 922 | $135,242 | $147 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 645 | $77,377 | $120 |
| Ultrasound of leg arteries or artery grafts | 336 | $65,932 | $196 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 52 | $45,919 | $820 |
| Professional services for outpatient pulmonary rehabilitation, per session | 26 | $23,340 | $73 |
| Heart muscle strain imaging | 769 | $23,162 | $30 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 125 | $14,321 | $47 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 821 | $12,198 | $14 |
| Test to measure oxygen level in blood using ear or finger device continuously overnight | 71 | $11,001 | $27 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 88 | $9,386 | $47 |
| Ultrasound scan of abdominal aorta | 68 | $7,427 | $109 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 75 | $7,405 | $38 |
| Test to determine lung volumes using sensors | 27 | $2,504 | $20 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 108 | $2,201 | $20 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 15 | $1,106 | $61 |
| Return visit (30+ min) | 11 | $931 | $85 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
2,422 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 15% · Women 56% · Also on Medicaid 48% · Health risk score 1.88. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 55% · Coronary heart disease 42% · Depression 42% · Chronic kidney disease 37% · COPD 32% · Heart failure 29% · Dementia 28% · Atrial fibrillation 22% · Stroke 18% · Cancer 11%.
The office billed $2,351,154, Medicare allowed $970,191 and paid $781,026; for 9,009 services of 46 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 2,422 | 9,009 | 75 | 1.88 | $2,351,154 | $781,026 |
| 2023 | 532 | 1,995 | 77 | 2.18 | $420,904 | $128,746 |
| 2022 | 51 | 72 | 71 | 1.27 | $64,901 | $17,335 |
| 2021 | 65 | 78 | 73 | 1.28 | $77,508 | $22,051 |
| 2020 | 63 | 86 | 73 | 1.51 | $82,185 | $22,455 |
| 2019 | 183 | 221 | 70 | 1.64 | $143,831 | $37,559 |
| 2018 | 269 | 460 | 70 | 1.50 | $187,358 | $50,358 |
| 2017 | 338 | 568 | 71 | 1.48 | $256,478 | $69,236 |
| 2016 | 278 | 520 | 71 | 1.57 | $185,569 | $50,862 |
| 2015 | 328 | 707 | 72 | 1.58 | $211,655 | $54,347 |
| 2014 | 216 | 469 | 70 | 1.62 | $188,158 | $56,466 |
| 2013 | 1,806 | 5,836 | 73 | 1.49 | $2,131,528 | $429,550 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Professional services for outpatient pulmonary rehabilitation with continuous monitoring of blood oxygen, per session | 29 | $24,427 | $74 |
| Professional services for outpatient pulmonary rehabilitation, per session | 36 | $20,626 | $51 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 207 | $15,527 | $48 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 98 | $14,841 | $84 |
| Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | 200 | $11,167 | $37 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 40 | $7,907 | $198 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 81 | $4,403 | $54 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $3,359 | $102 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 40 | $3,349 | $45 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 18 | $1,642 | $47 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,630 | $136 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 21 | $1,488 | $36 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,487 | $62 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 36 | $660 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $179 | $13 |
2022: 2 services
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 36 | $7,143 | $198 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 11 | $5,679 | $516 |
2021: 1 service
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 41 | $9,162 | $218 |
2020: 2 services
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 52 | $10,891 | $209 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $4,966 | $451 |
2019: 5 services
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 81 | $17,471 | $216 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $6,614 | $441 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 13 | $2,158 | $166 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 35 | $2,046 | $58 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 24 | $1,625 | $62 |
2018: 7 services
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 84 | $18,618 | $219 |
| Short return visit (20+ min) | 129 | $9,430 | $55 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 18 | $4,401 | $245 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 15 | $4,347 | $290 |
| Return visit (30+ min) | 23 | $1,900 | $83 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 30 | $1,335 | $45 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 33 | $504 | $13 |
2017: 11 services
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 99 | $21,889 | $217 |
| Short return visit (20+ min) | 145 | $9,930 | $55 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $7,309 | $457 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 21 | $4,960 | $236 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 22 | $3,829 | $174 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $3,507 | $292 |
| New patient visit (45+ min) | 27 | $3,385 | $125 |
| Return visit (30+ min) | 16 | $1,398 | $82 |
| Short return visit (20+ min) | 32 | $1,312 | $34 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 16 | $797 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $245 | $12 |
2016: 11 services
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 87 | $20,835 | $237 |
| Short return visit (20+ min) | 107 | $5,566 | $38 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 17 | $4,510 | $265 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 11 | $2,450 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $1,779 | $56 |
| Short return visit (20+ min) | 27 | $1,610 | $56 |
| New patient visit (45+ min) | 11 | $1,383 | $126 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 22 | $1,090 | $50 |
| Return visit (30+ min) | 18 | $970 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 60 | $495 | $6 |
| Short return visit | 12 | $234 | $19 |
2015: 8 services
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 91 | $20,877 | $227 |
| Short return visit (20+ min) | 146 | $8,133 | $37 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 126 | $6,183 | $48 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 16 | $4,065 | $254 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 58 | $3,125 | $54 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 13 | $2,498 | $192 |
| Return visit (30+ min) | 16 | $939 | $59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 82 | $568 | $6 |
2014: 9 services
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 100 | $23,670 | $230 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 21 | $5,647 | $269 |
| Short return visit (20+ min) | 103 | $5,174 | $38 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $3,680 | $283 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 60 | $3,305 | $55 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 14 | $2,349 | $168 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 18 | $891 | $50 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 12 | $837 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 14 | $99 | $7 |
2013: 46 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 440 | $121,978 | $216 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 127 | $59,554 | $239 |
| Return visit (30+ min) | 357 | $34,948 | $68 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 257 | $31,881 | $64 |
| Injection, regadenoson, 0.1 mg | 139 | $23,224 | None |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 71 | $15,184 | $214 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 261 | $11,876 | $45 |
| Short return visit (20+ min) | 210 | $11,649 | $47 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 126 | $10,658 | $77 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $8,809 | $149 |
| Ultrasound of both sides of head and neck blood flow | 63 | $8,405 | $63 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 132 | $7,450 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 67 | $5,807 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 414 | $5,549 | $11 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 45 | $4,543 | $101 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 16 | $3,536 | $208 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 38 | $2,824 | $74 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 97 | $2,549 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 337 | $2,462 | $6 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 18 | $2,374 | $61 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 14 | $2,302 | $92 |
| Hospital discharge day management, 30 minutes or less | 41 | $2,279 | $53 |
| Long return visit (40+ min) | 22 | $2,147 | $93 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 39 | $2,064 | $29 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 16 | $1,960 | $63 |
| Initial hospital observation care per day, typically 70 minutes | 13 | $1,657 | $127 |
| New patient visit (30+ min) | 22 | $1,595 | $73 |
| Ultrasound of leg arteries or artery grafts | 50 | $1,331 | $27 |
| Testing of autonomic nervous system function and heart rate response to deep breathing | 20 | $1,247 | $59 |
| Ultrasound of both sides of head and neck blood flow | 60 | $1,218 | $20 |
| Short return visit | 39 | $1,106 | $28 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $1,032 | $74 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 17 | $988 | $58 |
| Testing of autonomic (sympathetic) nervous system function, heart rate response to breathing exercises, and passive tilt | 20 | $936 | $45 |
| New patient visit (15+ min) | 18 | $923 | $51 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 46 | $902 | $15 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 41 | $822 | $20 |
| Hospital observation care on day of discharge | 15 | $769 | $51 |
| Electrocardiogram (ecg) 2-day continuous | 39 | $764 | $19 |
| Telephonic rhythm strip evaluation of single, dual, multiple lead or leadless pacemaker system, up to 90 days | 17 | $751 | $28 |
| Short return visit (20+ min) | 21 | $674 | $29 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 19 | $506 | $14 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 13 | $248 | $15 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 19 | $194 | $10 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $168 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $34 | $3 |
Medicaid work
$101,681 in 2024
Medicaid paid $101,681 for 1,108 billed services this clinician did in 2024, up to 74 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 287 | $30,703 |
| VASCULAR STUDY | 228 | $22,796 |
| LOWER EXTREMITY STUDY | 139 | $22,243 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 218 | $21,062 |
| Myocardial strain imaging using speckle tracking-derived assessment of myocardial mechanics (List separately in addition to codes for echocardiography imaging) | 176 | $3,918 |
| Ultrasound, abdominal aorta, real time with image documentation, screening study for abdominal aortic aneurysm (AAA) | 13 | $650 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 47 | $308 |
| 2024 | 1,108 | 7 | 74 | $101,681 |
| 2023 | 31 | 1 | 14 | $1,435 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 31 | $1,435 |
Drugs they prescribed that Part D paid
$943
Pharmacies billed $943 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
68 generic and 0 brand-name prescriptions · $943 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Bicalutamide | 12 | $235 | $20 |
| Enalapril Maleate | 12 | $37 | $3 |
Year by year
| 2024 | 68 | None | None | 0% | $943 |
| 2023 | 52 | None | None | None | $1,582 |
| 2022 | 40 | None | 0% (0) | None | $2,504 |
| 2021 | 1,261 | 151 | 0% (0) | 2% | $875,493 |
| 2020 | 50 | 12 | None | None | $3,659 |
| 2019 | 151 | 45 | 0% (0) | 26% | $17,208 |
| 2018 | 824 | 121 | None | 18% | $90,554 |
| 2017 | 1,025 | 155 | None | 24% | $416,411 |
| 2016 | 527 | 71 | None | 24% | $37,788 |
| 2015 | 426 | 70 | 0% (0) | 22% | $24,409 |
| 2014 | 2,194 | 279 | None | 25% | $131,497 |
| 2013 | 5,196 | 409 | None | 26% | $298,035 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Bicalutamide | 12 | $252 | $21 |
2022: 2 drugs
| Testosterone Cypionate | 14 | $751 | $54 |
| Bicalutamide | 12 | $289 | $24 |
2021: 11 drugs
| Ketoprofen | 181 | $454,905 | $2,513 |
| Halobetasol Propionate | 336 | $100,190 | $298 |
| Calcipotriene | 113 | $65,153 | $577 |
| Cyclobenzaprine | 197 | $55,348 | $281 |
| Mupirocin | 19 | $33,178 | $1,746 |
| Fluocinonide-E | 101 | $23,978 | $237 |
| Ergotamine-Caffeine | 23 | $22,363 | $972 |
| Triamcinolone Acetonide | 31 | $20,280 | $654 |
| Lidocaine-Prilocaine | 111 | $8,333 | $75 |
| Naftifine | 11 | $5,365 | $488 |
| Methocarbamol | 45 | $1,234 | $27 |
2020: 2 drugs
| Bicalutamide | 12 | $433 | $36 |
| Tamsulosin | 12 | $47 | $4 |
2019: 5 drugs
| Myrbetriq | 15 | $6,084 | $406 |
| Eliquis | 12 | $4,978 | $415 |
| Bicalutamide | 12 | $295 | $25 |
| Tamsulosin | 17 | $199 | $12 |
| Clopidogrel | 11 | $82 | $7 |
2018: 25 drugs
| Ranexa | 20 | $12,833 | $642 |
| Eliquis | 22 | $9,986 | $454 |
| Brilinta | 22 | $9,273 | $421 |
| Xarelto | 15 | $7,781 | $519 |
| Myrbetriq | 13 | $6,389 | $491 |
| Atorvastatin | 103 | $1,559 | $15 |
| Amlodipine-Valsartan-Hctz | 16 | $1,417 | $89 |
| Rosuvastatin | 28 | $1,209 | $43 |
| Nitroglycerin | 13 | $1,129 | $87 |
| Clopidogrel | 82 | $774 | $9 |
| Metoprolol | 51 | $713 | $14 |
| Isosorbide Mononitrate Er | 24 | $712 | $30 |
| Amlodipine Besylate-Benazepril | 18 | $392 | $22 |
| Finasteride | 11 | $387 | $35 |
| Metoprolol | 57 | $335 | $6 |
| Tamsulosin | 26 | $335 | $13 |
| Cartia Xt | 13 | $305 | $23 |
| Bicalutamide | 12 | $238 | $20 |
| Lisinopril | 31 | $196 | $6 |
| Amlodipine Besylate | 31 | $181 | $6 |
| Carvedilol | 33 | $164 | $5 |
| Spironolactone | 28 | $139 | $5 |
| Dutasteride | 12 | $135 | $11 |
| Furosemide | 46 | $121 | $3 |
| Losartan | 15 | $52 | $3 |
2017: 23 drugs
| Doxepin | 103 | $242,272 | $2,352 |
| Lidocaine | 131 | $84,956 | $649 |
| Diclofenac | 70 | $30,988 | $443 |
| Xarelto | 29 | $11,237 | $387 |
| Ranexa | 13 | $9,627 | $741 |
| Rosuvastatin | 13 | $872 | $67 |
| Clopidogrel | 68 | $767 | $11 |
| Atorvastatin | 43 | $736 | $17 |
| Metoprolol | 30 | $692 | $23 |
| Tamsulosin | 42 | $622 | $15 |
| Amlodipine Besylate-Benazepril | 31 | $594 | $19 |
| Dutasteride | 11 | $473 | $43 |
| Isosorbide Mononitrate Er | 26 | $353 | $14 |
| Metoprolol | 67 | $345 | $5 |
| Finasteride | 15 | $332 | $22 |
| Amlodipine Besylate | 32 | $292 | $9 |
| Bicalutamide | 12 | $202 | $17 |
| Spironolactone | 25 | $196 | $8 |
| Lisinopril | 28 | $178 | $6 |
| Carvedilol | 45 | $176 | $4 |
| Furosemide | 49 | $149 | $3 |
| Warfarin | 13 | $101 | $8 |
| Hydrochlorothiazide | 11 | $35 | $3 |
2016: 18 drugs
| Xarelto | 21 | $7,530 | $359 |
| Multaq | 15 | $4,151 | $277 |
| Brilinta | 13 | $4,031 | $310 |
| Avodart | 11 | $1,871 | $170 |
| Metoprolol | 36 | $661 | $18 |
| Amlodipine Besylate-Benazepril | 38 | $634 | $17 |
| Tamsulosin | 39 | $584 | $15 |
| Atorvastatin | 29 | $450 | $16 |
| Clopidogrel | 39 | $404 | $10 |
| Spironolactone | 31 | $204 | $7 |
| Bicalutamide | 12 | $182 | $15 |
| Metoprolol | 54 | $168 | $3 |
| Finasteride | 22 | $146 | $7 |
| Warfarin | 21 | $145 | $7 |
| Isosorbide Mononitrate Er | 11 | $107 | $10 |
| Carvedilol | 32 | $100 | $3 |
| Furosemide | 19 | $57 | $3 |
| Amlodipine Besylate | 12 | $39 | $3 |
2015: 15 drugs
| Ranexa | 20 | $7,440 | $372 |
| Brilinta | 17 | $4,808 | $283 |
| Avodart | 12 | $1,976 | $165 |
| Metoprolol | 54 | $803 | $15 |
| Amlodipine Besylate-Benazepril | 28 | $503 | $18 |
| Tamsulosin | 27 | $442 | $16 |
| Atorvastatin | 22 | $279 | $13 |
| Isosorbide Mononitrate Er | 21 | $257 | $12 |
| Clopidogrel | 28 | $218 | $8 |
| Bicalutamide | 12 | $175 | $15 |
| Finasteride | 11 | $105 | $10 |
| Metoprolol | 25 | $91 | $4 |
| Carvedilol | 11 | $79 | $7 |
| Lisinopril | 13 | $65 | $5 |
| Amlodipine Besylate | 15 | $44 | $3 |
2014: 42 drugs
| Crestor | 113 | $23,820 | $211 |
| Xarelto | 79 | $20,273 | $257 |
| Pradaxa | 44 | $14,133 | $321 |
| Multaq | 33 | $11,140 | $338 |
| Ranexa | 33 | $9,204 | $279 |
| Metoprolol | 171 | $3,843 | $22 |
| Brilinta | 13 | $3,367 | $259 |
| Diovan | 15 | $3,035 | $202 |
| Betapace | 11 | $2,685 | $244 |
| Exforge | 12 | $1,923 | $160 |
| Avodart | 12 | $1,709 | $142 |
| Clopidogrel | 127 | $1,528 | $12 |
| Digox | 39 | $1,449 | $37 |
| Spironolactone | 90 | $1,067 | $12 |
| Atorvastatin | 61 | $850 | $14 |
| Metoprolol | 153 | $818 | $5 |
| Pravastatin | 30 | $791 | $26 |
| Valsartan-Hydrochlorothiazide | 18 | $771 | $43 |
| Simvastatin | 88 | $770 | $9 |
| Amlodipine Besylate | 111 | $739 | $7 |
| Digoxin | 23 | $650 | $28 |
| Carvedilol | 87 | $597 | $7 |
| Lisinopril | 124 | $593 | $5 |
| Sotalol | 33 | $580 | $18 |
| Cilostazol | 18 | $576 | $32 |
| Nifedipine Er | 18 | $482 | $27 |
| Warfarin | 47 | $465 | $10 |
| Potassium Chloride | 22 | $326 | $15 |
| Diltiazem 24hr Er | 17 | $293 | $17 |
| Bicalutamide | 12 | $235 | $20 |
| Isosorbide Mononitrate Er | 16 | $206 | $13 |
| Furosemide | 71 | $183 | $3 |
| Torsemide | 11 | $173 | $16 |
| Amiodarone | 23 | $152 | $7 |
| Ramipril | 22 | $144 | $7 |
| Benazepril | 17 | $126 | $7 |
| Tamsulosin | 13 | $126 | $10 |
| Hydrochlorothiazide | 42 | $123 | $3 |
| Atenolol | 36 | $123 | $3 |
| Lisinopril-Hydrochlorothiazide | 23 | $119 | $5 |
| Finasteride | 11 | $110 | $10 |
| Omeprazole | 17 | $109 | $6 |
2013: 62 drugs
| Crestor | 309 | $62,020 | $201 |
| Pradaxa | 145 | $42,851 | $296 |
| Xarelto | 133 | $34,211 | $257 |
| Multaq | 71 | $23,040 | $325 |
| Ranexa | 47 | $12,291 | $262 |
| Clopidogrel | 308 | $11,989 | $39 |
| Metoprolol | 362 | $9,801 | $27 |
| Diovan | 34 | $6,294 | $185 |
| Effient | 25 | $5,781 | $231 |
| Exforge | 34 | $5,005 | $147 |
| Valsartan-Hydrochlorothiazide | 59 | $4,856 | $82 |
| Spironolactone | 259 | $3,803 | $15 |
| Coreg Cr | 24 | $3,659 | $152 |
| Micardis | 13 | $3,604 | $277 |
| Atorvastatin | 147 | $3,422 | $23 |
| Antara | 13 | $2,574 | $198 |
| Clonidine | 13 | $2,555 | $197 |
| Bidil | 11 | $2,136 | $194 |
| Amlodipine Besylate | 271 | $2,024 | $7 |
| Carvedilol | 208 | $1,682 | $8 |
| Lisinopril | 328 | $1,662 | $5 |
| Simvastatin | 186 | $1,658 | $9 |
| Metoprolol | 276 | $1,645 | $6 |
| Avodart | 12 | $1,580 | $132 |
| Azor | 12 | $1,569 | $131 |
| Sotalol | 76 | $1,554 | $20 |
| Amlodipine Besylate-Benazepril | 32 | $1,478 | $46 |
| Pravastatin | 93 | $1,373 | $15 |
| Cilostazol | 44 | $1,369 | $31 |
| Warfarin | 127 | $1,322 | $10 |
| Toprol Xl | 14 | $1,225 | $88 |
| Fenofibrate | 30 | $1,028 | $34 |
| Ramipril | 69 | $1,007 | $15 |
| Digox | 86 | $957 | $11 |
| Isosorbide Mononitrate Er | 56 | $919 | $16 |
| Isosorbide Dinitrate | 24 | $854 | $36 |
| Potassium Chloride | 58 | $832 | $14 |
| Eplerenone | 12 | $827 | $69 |
| Amiodarone | 61 | $731 | $12 |
| Furosemide | 176 | $674 | $4 |
| Losartan | 46 | $625 | $14 |
| Diltiazem 24hr Er | 27 | $570 | $21 |
| Acetazolamide | 13 | $516 | $40 |
| Hydralazine | 18 | $392 | $22 |
| Digoxin | 68 | $372 | $5 |
| Nitrostat | 34 | $371 | $11 |
| Torsemide | 28 | $357 | $13 |
| Omeprazole | 26 | $339 | $13 |
| Finasteride | 13 | $326 | $25 |
| Atenolol | 75 | $308 | $4 |
| Lisinopril-Hydrochlorothiazide | 49 | $290 | $6 |
| Clonidine | 30 | $248 | $8 |
| Bicalutamide | 11 | $238 | $22 |
| Hydrochlorothiazide | 86 | $237 | $3 |
| Tamsulosin | 18 | $237 | $13 |
| Jantoven | 18 | $227 | $13 |
| Benazepril | 30 | $200 | $7 |
| Doxazosin Mesylate | 18 | $194 | $11 |
| Pantoprazole | 20 | $167 | $8 |
| Verapamil Er | 12 | $158 | $13 |
| Enalapril Maleate | 31 | $137 | $4 |
| Allopurinol | 13 | $110 | $8 |
Money from drug and device companies
$130 in 2025
| 2025 | 2 | 2 | None | $130 |
| 2023 | 2 | 2 | None | $213 |
| 2020 | 1 | 1 | None | $21 |
| 2019 | 2 | 3 | None | $52 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abiomed | None | $104 | 1 payment
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $26 | 1 payment
|
See all 2 published payments
| Abiomed | Meals · 2025-09-10 | None | $104 |
| Edwards Lifesciences | Meals · 2025-05-01 | Sapien 3 Ultra Resilia | $26 |
See earlier years (2023, 2020, 2019)
2023: $213
| Inari Medical | Flowtriever Catheter, S | $132 | 1 payment
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $81 | 1 payment
|
2020: $21
| Acist Medical Systems | Cvi Consumables | $21 | 1 payment
|
2019: $52
| Sanofi-Aventis U.S. | Praluent | $31 | 2 payments
|
| Amgen | Repatha | $21 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 94.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1649273715
- Licence
- NY 183914New Jersey 25MA12040100: Active
- Trained
- State University of New York at Buffalo School of Medicine, 1988
- Group
- Kaleida Health · General Physician PC · Cupid Medical Psc · Prescott Healthcare Solutions LLC · Cupid Medical of California PC
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- NY 01365920
- Taxonomy
- Cardiology (207RC0000X); Federal specialty code 207UN0901X (207UN0901X)
- Mailing address
- 86 Navesink Ave, Rumson, NJ, 07760
- NPI first listed
- 2005-05-23
- NPI last updated
- 2026-06-02
- NPI record certified
- 2026-06-02
This is when the NPI record was last certified, not a medical board exam.